M. A. Velders

发表

Long-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trial.

P. Smits, S. Hofma, A. W. van ‘t Hof, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention.

S. le Cessie, T. Ahmed, Bas L van der Hoeven, 2013, The American journal of cardiology.

Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction

E. Hagström, J. Ärnlöv, T. Fall, 2019, Upsala journal of medical sciences.

Determinants of right ventricular remodeling following ST-segment elevation myocardial infarction.

Jeroen J. Bax, M. Schalij, V. Delgado, 2014, The American journal of cardiology.

Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.

C. Cannon, W. Weaver, A. Siegbahn, 2017, Clinical chemistry.

In-hospital major bleeding and its clinical relevance in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.

Bas L van der Hoeven, M. Schalij, S. Cannegieter, 2013, The American journal of cardiology.

General introduction and outline of the thesis

M. A. Velders, 2014 .

With ST Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

M. Schalij, S. Cannegieter, M. A. Velders, 2013 .

OUTCOME OF SECOND-GENERATION EVEROLIMUS- AND ZOTAROLIMUS-ELUTING STENTS IN ST-ELEVATION MYOCARDIAL INFARCTION

E. Wall, J. Jukema, M. Schalij, 2012 .

Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up

Jeroen J. Bax, D. Atsma, M. Schalij, 2013, Journal of Cardiovascular Translational Research.

Prognostic Implications of Elevated Pulmonary Artery Pressure After ST-Segment Elevation Myocardial Infarction.

Jeroen J. Bax, M. Schalij, H. Vliegen, 2016, The American journal of cardiology.

Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial.

A. Siegbahn, L. Wallentin, R. Becker, 2015, American heart journal.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention.

J. Jukema, Bas L van der Hoeven, M. Schalij, 2013, The American journal of cardiology.

Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention

D. Ardissino, B. Meier, L. Wallentin, 2016, Heart.

Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials.

S. Hahn, Si‐Hyuck Kang, D. Kandzari, 2013, American heart journal.

Association between angiographic culprit lesion and out-of-hospital cardiac arrest in ST-elevation myocardial infarction patients.

M. Kuiper, J. Jukema, M. Schalij, 2013, Resuscitation.

Objectives Background Methods Results Conclusions

P. Smits, S. Hofma, J. Brouwer, 2022 .

Long-term outcome of second-generation everolimus-eluting stents and Endeavor zotarolimus-eluting stents in a prospective registry of ST-elevation myocardial infarction patients.

J. Jukema, Bas L van der Hoeven, M. Schalij, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Prognosis of elderly patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention in 2001 to 2011: A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) registry.

M. Schalij, G. Sarno, S. James, 2014, American heart journal.

Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction

P. Smits, S. Hofma, J. Brouwer, 2014, Netherlands Heart Journal.

Influence of gender on ischemic times and outcomes after ST-elevation myocardial infarction.

J. Jukema, Bas L van der Hoeven, M. Schalij, 2013, The American journal of cardiology.

Optimization of care for ST-elevation myocardial infarction

M. A. Velders, 2014 .

Call-to-balloon time dashboard in patients with ST-segment elevation myocardial infarction results in significant improvement in the logistic chain.

Martin J Schalij, M. Schalij, V. Umans, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents

S. Hofma, J. Brouwer, A. V. van Boven, 2013, PloS one.

CHAPTER 8 Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stents

S. Hofma, J. Brouwer, M. A. Velders, 2014 .

Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction: A Nationwide Study

E. Hagström, S. James, M. A. Velders, 2020, Journal of the American Heart Association.

Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.

P. Smits, S. Hofma, J. Brouwer, 2012, Journal of the American College of Cardiology.

ROLE OF ADMISSION CARDIAC BIOMARKERS IN RISK STRATIFICATION OF PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES TRIAL

A. Siegbahn, L. Wallentin, R. Becker, 2014 .

Bleeding, Thrombosis, Embolization, and Other ComplicationsTCT-557 The Risk of In-Hospital Bleeding and Long-Term Mortality in Patients with ST Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

M. Schalij, M. A. Velders, H. Boden, 2012 .